1. Home
  2. MOVE vs VIVS Comparison

MOVE vs VIVS Comparison

Compare MOVE & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movano Inc.

MOVE

Movano Inc.

HOLD

Current Price

$8.57

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

HOLD

Current Price

$1.98

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOVE
VIVS
Founded
2018
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
8.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MOVE
VIVS
Price
$8.57
$1.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
139.2K
41.6K
Earning Date
03-19-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$500,000.00
$140,000.00
Revenue This Year
$1,460.71
$42.38
Revenue Next Year
$96.77
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.92
52 Week Low
$4.67
$1.41
52 Week High
$69.68
$21.96

Technical Indicators

Market Signals
Indicator
MOVE
VIVS
Relative Strength Index (RSI) 48.65 36.62
Support Level $7.22 $2.11
Resistance Level $9.72 $2.51
Average True Range (ATR) 1.08 0.15
MACD -0.29 0.00
Stochastic Oscillator 29.48 10.97

Price Performance

Historical Comparison
MOVE
VIVS

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: